NORD Issues Statement Applauding the Approval of Ensuring Access to Clinical Trials Act
Written by Jennifer Huron on September 29, 2015
The following statement was issued by Peter L. Saltonstall, President and CEO of the National Organization for Rare Disorders (NORD), on yesterday’s approval of the Ensuring Access to Clinical Trials Act (S. 139) in the United States House of Representatives.
The House of Representatives echoed the U.S. Senate and… Read More